Intracranial Outcomes of 1L Selpercatinib in Advanced RET fusion-positive (RET plus ) NSCLC: LIBRETTO-431 study

被引：0
|
作者：
Perol, Maurice [1 ]
Solomon, Ben J. [2 ]
Goto, Koichi [3 ]
Park, Keunchil [4 ]
Nadal, Ernest [5 ]
Bria, Emilio [6 ]
Martin, Claudio [7 ]
Bar, Jair [8 ]
Williams, Justin [9 ]
Puri, Tarun [9 ]
Li, Jian [10 ]
Uh, Minji [9 ]
Lin, Boris [9 ]
Zhou, Caicun [11 ]
Pruthi, Aarohan [9 ]
机构：
[1] Ctr Leon Berard, Lyon, France
[2] Peter MacCallum Canc Inst, Melbourne, Vic, Australia
[3] Natl Canc Ctr Hosp East, Chiba, Japan
[4] Samsung Med Ctr, Seoul, South Korea
[5] Inst Catala Oncol, Barcelona, Spain
[6] Fdn Policlin Univ Agostino Gemelli IRCCS, Rome, Italy
[7] Inst Alexander Fleming, Buenos Aires, DF, Argentina
[8] Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel
[9] Eli Lilly, Indianapolis, IN USA
[10] Loxo Lilly, Indianapolis, IN USA
[11] Shanghai Pulm Hosp, Shanghai, Peoples R China
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
259
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [1] Intracranial outcomes of 1L selpercatinib in advanced RET fusion-positive NSCLC: LIBRETTO-431 study.
    Perol, Maurice
    Goto, Koichi
    Solomon, Benjamin J.
    Park, Keunchil
    Nadal, Ernest
    Bria, Emilio
    Martin, Claudio
    Bar, Jair
    Williams, Justin
    Puri, Tarun
    Li, Jian
    Uh, Minji
    Lin, Boris K.
    Zhou, Caicun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Intracranial outcomes of 1L selpercatinib in advanced RET fusion-positive NSCLC: LIBRETTO-431 study.
    Uh, Minji
    Perol, Maurice
    Goto, Koichi
    Solomon, Benjamin J.
    Park, Keunchil
    Nadal, Ernest
    Bria, Emilio
    Martin, Claudio
    Bar, Jair
    Williams, Justin
    Puri, Tarun
    Li, Jian
    Lin, Boris K.
    Zhou, Caicun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 199 - 199
  • [3] Efficacy and safety of 1L selpercatinib in RET fusion-positive NSCLC: LIBRETTO-431 East Asian subgroup analysis.
    Cheng, Ying
    Loong, Herbert H.
    Zhou, Caicun
    Nishino, Kazumi
    Lee, Dae Ho
    Lee, Se-Hoon
    Yang, James Chih-Hsin
    Liu, Dan
    Rajakumar, Deborah
    Han, Hongmei
    Puri, Tarun
    Lin, Aimee Bence
    Goto, Koichi
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 214 - 214
  • [4] Efficacy of Selpercatinib by RET Fusion Partner in RET plus NSCLC: Results from the LIBRETTO-001 and LIBRETTO-431 Trials
    Solomon, B.
    Drilon, A.
    Park, K.
    Novello, S.
    Nadal, E.
    Besse, B.
    Peled, N.
    Peterson, P.
    Barker, S.
    Szpurka, A.
    Grbovic-Huezo, O.
    Loong, H.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S204 - S205
  • [5] Efficacy of selpercatinib by RET fusion partner in RET plus NSCLC: Results from the LIBRETTO-001 and LIBRETTO-431 trials
    Solomon, Ben
    Drilon, Alexander
    Park, Keunchil
    Novello, Silvia
    Nadal, Ernest
    Besse, Benjamin
    Peled, Nir
    Peterson, Patrick
    Barker, Scott
    Szpurka, Anna M.
    Grbovic-Huezo, Olivera
    Loong, Herbert H.
    Pruthi, Aarohan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 : 139 - 139
  • [6] LIBRETTO-431: Selpercatinib in treatment (Tx)-naive patients with RET fusion-positive (RET plus ) non-small cell lung cancer (NSCLC)
    Loong, H. H. F.
    Goto, K.
    Elamin, Y. Y.
    Solomon, B.
    Santini, F. C.
    Soldatenkova, V.
    Sashegyi, A.
    Lin, A. Bence
    Lin, B. K.
    Wolf, J.
    Oxnard, G. R.
    Zhou, C.
    Drilon, A.
    Park, K.
    ANNALS OF ONCOLOGY, 2020, 31 : S893 - S893
  • [7] Selpercatinib: A Review in Advanced RET Fusion-Positive NSCLC
    Tina Nie
    Yahiya Y. Syed
    Targeted Oncology, 2023, 18 : 169 - 176
  • [8] Selpercatinib: A Review in Advanced RET Fusion-Positive NSCLC
    Nie, Tina
    Syed, Yahiya Y.
    TARGETED ONCOLOGY, 2023, 18 (01) : 169 - 176
  • [9] LIBRETTO-431: Selpercatinib in Treatment-Naive Patients with RET Fusion-Positive Non-Small Cell Lung Cancer (NSCLC).
    Goto, K.
    Wolf, J.
    Elamin, Y.
    Santini, F.
    Soldatenkova, V.
    Sashegyi, A.
    Lin, A. Bence
    Lin, B.
    Novello, S.
    Arriola Aperribay, E.
    Perol, M.
    Loong, H.
    Drilon, A.
    Park, K.
    Solomon, B.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S228 - S229
  • [10] LIBRETTO-431: Confirming the Superiority of Selpercatinib to Chemotherapy and the Lack of Efficacy of Immune Checkpoint Inhibitors in Advanced RET Fusion-Positive (RET plus ) NSCLC, Another Unique Never-Smoker Predominant Molecular Subtype of NSCLC
    Lee, Alexandria T. M.
    Ou, Sai-Hong Ignatius
    LUNG CANCER-TARGETS AND THERAPY, 2024, 15 : 75 - 80
12345